Review
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Transl Med. Aug 12, 2014; 3(2): 69-83
Published online Aug 12, 2014. doi: 10.5528/wjtm.v3.i2.69
Assessment of platelet function: Laboratory and point-of-care methods
Rita Paniccia, Raffaella Priora, Agatina Alessandrello Liotta, Niccolò Maggini, Rosanna Abbate
Rita Paniccia, Raffaella Priora, Rosanna Abbate, Department of Experimental and Clinical Medicine, Thrombosis Center, University of Florence, 50134 Florence, Italy
Rita Paniccia, Raffaella Priora, Agatina Alessandrello Liotta, Niccolò Maggini, Rosanna Abbate, Department of Heart and Vessels, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy
Author contributions: Paniccia R conceived and designed the review, prepared the manuscript and searched literature; Priora R contributed to literature review and preparation of the manuscript; Alessandrello Liotta A and Maggini N contributed to editing and finalizing the manuscript; Abbate R approved of the version to be published.
Correspondence to: Rita Paniccia, MSc, Department of Experimental and Clinical Medicine, Thrombosis Center, University of Florence, Viale Pieraccini, 19, 50134 Florence, Italy. rita.paniccia@unifi.it
Telephone: +39-055-7949419 Fax: +39-055-7949929
Received: January 2, 2014
Revised: March 14, 2014
Accepted: April 25, 2014
Published online: August 12, 2014
Abstract

In the event of blood vessel damage, human platelets are promptly recruited on the site of injury and, after their adhesion, activation and aggregation, prevent blood loss with the formation of a clot. The consequence of abnormal regulation can be either hemorrhage or the development of thrombosis. Qualitative and/or quantitative defects in platelets promote bleeding, whereas the residual reactivity of platelets, despite antiplatelet therapies, play an important role in promoting arterial thrombotic complications. Platelet function is traditionally assessed to investigate the origin of a bleeding syndrome, to predict the risk of bleeding prior surgery or during pregnancy or to monitor the efficacy of antiplatelet therapy in thrombotic syndromes that, now, can be considered a new discipline. “Old” platelet function laboratory tests such as the evaluation of bleeding time and the platelet aggregation analysis in platelet-rich plasma are traditionally utilized to aid in the diagnosis and management of patients with platelet and hemostatic disorders and used as diagnostic tools both in bleeding and thrombotic diathesis in specialized laboratories. Now, new and renewed automated systems have been introduced to provide a simple, rapid assessment of platelet function including point of care methods. These new methodologies are also suitable for being used in non-specialized laboratories and in critical area for assessing platelet function in whole blood without the requirement of sample processing. Some of these methods are also beginning to be incorporated into routine clinical use and can be utilized as not only as first panel for the diagnosis of platelet dysfunction, but also for monitoring anti-platelet therapy and to potentially assess risk of both bleeding and/or thrombosis.

Keywords: Platelets, Method, Test, Point of care testing, Laboratory assessment, Bleeding, Thrombosis, Platelet function

Core tip: This review discussed the scenario of available platelet function laboratory and point-of-care methods suitable in different clinical setting. As this matter has become of crucial importance in the bleeding management and for monitoring antiplatelet therapies, improved ability to assess platelet function in a timely and efficient manner is essential. Traditional platelet function methods, requiring a fair degree of expertise, have been limited to specialized laboratory. Many efforts have been carried out for improving platelet function assays for centralized laboratory, such as different point-of-care testing methodologies have been developed. Moreover, different guidelines and recommendations for their method standardization are growing.